share_log

4: Statement of changes in beneficial ownership of securities-Director Loewy Caroline M

4: Statement of changes in beneficial ownership of securities-Director Loewy Caroline M

4:持股變動聲明-董事 Loewy Caroline M
美股SEC公告 ·  06/14 06:49

牛牛AI助理已提取核心訊息

Caroline M. Loewy, associated with eFFECTOR Therapeutics, Inc. (EFTR), has been involved in a transaction dated 06/13/2024. Specific details regarding the nature of the transaction, including the number of shares, transaction price, and total value, have not been disclosed. The relationship of Loewy to the issuer was not specified in the announcement. Without these details, the impact of the transaction on Loewy's holdings and the overall market position of eFFECTOR Therapeutics remains unclear.
Caroline M. Loewy, associated with eFFECTOR Therapeutics, Inc. (EFTR), has been involved in a transaction dated 06/13/2024. Specific details regarding the nature of the transaction, including the number of shares, transaction price, and total value, have not been disclosed. The relationship of Loewy to the issuer was not specified in the announcement. Without these details, the impact of the transaction on Loewy's holdings and the overall market position of eFFECTOR Therapeutics remains unclear.
Caroline M. Loewy,與eFFECTOR Therapeutics,Inc.(EFTR)相關,參與2024年06/13日期的交易。未透露交易性質的具體細節,包括股份數量,交易價格和總價值。Loewy與發行者的關係未在公告中指定。沒有這些細節,交易對Loewy的持股和eFFECTOR Therapeutics的整體市場位置的影響仍不清楚。
Caroline M. Loewy,與eFFECTOR Therapeutics,Inc.(EFTR)相關,參與2024年06/13日期的交易。未透露交易性質的具體細節,包括股份數量,交易價格和總價值。Loewy與發行者的關係未在公告中指定。沒有這些細節,交易對Loewy的持股和eFFECTOR Therapeutics的整體市場位置的影響仍不清楚。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。